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+
Current state of HPV Vaccination 
n  HPV vaccination with Gardasil 9 approved for males (ages 11-21) and 
females (ages 11-26) which protects against 90% of strains that cause 
genital warts and 70% of strains that cause cervical cancer7 
n  Effective HPV vaccination:  
n  Within 6 years of vaccine introduction, 64% reduction of HPV type prevalence 
in females aged 14-19 and 34% reduction in those aged 20-241 
n  According to rates compiled by the CDC, burden of cervical cancer 




HPV Vaccination in CT 
n  Both initiation and completion of HPV vaccination in CT are 
suboptimal5, 




Is the vaccine cost 
effective?   
n  Currently $8 billion dollars spent in U.S. for the cost of screening 
for cervical cancer and follow-up, cervical cancer, 
oropharyngeal cancer, anogenital warts, and recurrent 
respiratory papillomatosis3 
n  HPV associated with 100% of cervical cancer, 90% of anal 
cancer, 40% vulvar/vaginal cancer, 12% oropharyngeal cancer, 
3% oral cancer2  
n  Incremental Cost Effectiveness Ratio of implementing HPV 
Vaccination in ages 12 and above with current cervical cancer 
screening as compared to screening alone was under $50,000 per 
QALY (quality-adjusted life year)2  
n  Considered cost-effective 
n  For women under 21, the ICER was under $100,000 per QALY2 
n  Vaccination is covered by insurance ($360 for 3 shots) 
+
Expert Opinion 
Program Manager- Immunization and Fund Development, 
Southwestern AHEC  
n  Current initiative: “You Are the Key to HPV Cancer Prevention.” 
National AHEC Program4 
n  Parents surveyed state main barriers to HPV Vaccination: 
n  Lack of strong physician recommendation 
n  HPV Education for the community 
n  Work with physicians to provide tools to educate parents and 
strongly recommend HPV Vaccination in similar fashion as TDaP 
and other vaccination 
+
Expert Opinion 
n  Public Health Official in Vaccine Promotion Campaign 
n  “There’s been a shift in CDC focus recently in HPV Vaccination 
Campaigns. Improving physician recommendation is vital to 
improving rates. Currently physicians are cherrypicking and 
vaccinating who they believe is at risk.”  
n  “Parents simply don’t know enough about HPV.” 
n  “The CDC is currently focused on initiation of vaccine series more so 
than the completion of the series. It’s difficult to get adolescents into 
the office multiple times.” 
n  “If you look at places that mandate the vaccine, you can see 
improvement in not only vaccination rates but also attitudes towards 
the HPV Vaccine.”  
n  “Potential ideas for initiatives include educating high schoolers about 
HPV so they can speak with middle schoolers in a peer-to-peer 
education model”  
+
Intervention 
n  CT AHEC Network AmeriCorps conducts biweekly session with 
high school students interested in health care professions 
regarding health disparities and public health 
n  Danbury High School and Henry Abbott Technical High School 
n  Several students stated, “I don’t even know what HPV is” 
n   INTERVENTION: Educational, interactive afterschool didactic 
sessions  
1.  Educate students about HPV, associated health risks, and the vaccine 
2.  Engage students in problem solving to address barriers to HPV 
vaccination and solutions at the community, health care, and national 
level 







n  Population n=18, ages 14-18, females n=17 
n  Pre survey response rate: 100% 
n  Post survey response rate: 44%** 
n  Prior to didactic session, perceived barriers to HPV vaccination: 
n  “Parents think it’ll cause cancer” 
n  “Side effects” 
n  “Parents think they’re too young” 
n  “Parents scared of vaccines, lack of health care” 
n  Post didactic session, students believed low rate of vaccination is due 
to:  
n  “Lack of education, they don’t understand STIs” 
n  “Doctors are not convincing enough” 
n  “Educating parents and children” 
Quantitative Results 
 Pre   Post        Pre    Post 
•  Student knowledge of when HPV vaccine should be administered was high pre and post lesson.  
•  Association between HPV and cancer strengthened. 
•  Still need to emphasize that use of condoms cannot completely prevent HPV transmission.  
+
Evaluation 
n  Students expressed better understanding of HPV, vaccination 
rates, and barriers to care 
n  Students scored an average of 55% on the pre-survey and 80% 
on the post-didactic survey (p =0.001)  
n  Session provided significant improvement in HPV knowledge 
n  Didactic sessions well received: “I really enjoyed the 
presentation, you did a great job. Thanks for sharing all the 
important information on the HPV vaccine. I found it very 
interesting!” 
n  Students empowered to become health educators in their own 
right 
n  Minimal improvement in understanding spread of HPV  
+
Limitations 
n  Student population interested in healthcare, more 
knowledgeable than average high school student 
n  Population 94% female (n=18) 
n  Due to time constraints, inability to coordinate educational 
session for parents and understand their concerns 
n  Short term evaluation of knowledge 
n  Poor response rate in post-survey 
+
Looking forward… 
n  Educational session addressing concerns of parents in relation to HPV and 
vaccination. (Difficult to organize in 5 weeks). 
n  Utilizing motivated high school students to educate the community about HPV 
Vaccination and cervical cancer screening 
 
 
n  Implementation of  “3 to Complete Reminder Program” by Gardasil which sends 
text reminders to parents when subsequent doses are due to help complete the 
series.3 
n  Implementation of HPV vaccine series as part of adolescent preventative checklist  
n  Tracking of HPV vaccination rates at Brookfield Family Practice 
+
The Bigger Picture 
n  Rhode Island has mandated HPV vaccination for entry into 7th 
grade with completion by 9th grade8 
n  Rates of vaccination in RI and D.C. where mandates occur have 
highest rates of vaccination among males and females 
n  Legal mandates may lead to higher vaccination rates 
n  Could eventually change attitudes towards HPV 
n  Survey attitudes towards HPV vaccination in states with 
mandates versus without mandates 
n  Cervical cancer disproportionately affects low and middle 
income countries where screening is not readily available6  
n  Worldwide HPV Vaccination and education campaigns are 
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